Global and United States Valsartan Market Insights, Forecast to 2027

Publisher Name :
Date: 15-Nov-2021
No. of pages: 158
Inquire Before Buying

Valsartan market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Valsartan market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For United States market, this report focuses on the Valsartan market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in United States.

Segment by Type

- 40 mg Tablets

- 80 mg Tablets

- 160 mg Tablets

- 320 mg Tablets

Segment by Application

- Hypertension

- Heart Failure

- Heart Attack

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- Novartis

- Sun Pharmaceutical

- Teva

- Mylan

- Alembic Pharmaceuticals

- Lupin

- Aurobindo Pharma

- Macleods Pharmaceuticals

- HETERO

- Torrent Pharmaceuticals

- Huaren Pharmaceutical

- Jubilant Pharma

- Amneal Pharmaceuticals

- Zhejiang Huahai Pharmaceutical

- Square Pharmaceuticals

- Unichem Laboratories

- LG Life Sciences

Global and United States Valsartan Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Valsartan Product Introduction
1.2 Market by Type
1.2.1 Global Valsartan Market Size Growth Rate by Type
1.2.2 40 mg Tablets
1.2.3 80 mg Tablets
1.2.4 160 mg Tablets
1.2.5 320 mg Tablets
1.3 Market by Application
1.3.1 Global Valsartan Market Size Growth Rate by Application
1.3.2 Hypertension
1.3.3 Heart Failure
1.3.4 Heart Attack
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Valsartan Market Size, Estimates and Forecasts
2.1.1 Global Valsartan Revenue 2016-2027
2.1.2 Global Valsartan Sales 2016-2027
2.2 Global Valsartan, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Valsartan Historical Market Size by Region (2016-2021)
2.3.1 Global Valsartan Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Valsartan Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Valsartan Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Valsartan Sales Forecast by Region (2022-2027)
2.4.2 Global Valsartan Revenue Forecast by Region (2022-2027)
3 Global Valsartan Competitor Landscape by Players
3.1 Global Top Valsartan Manufacturers by Sales
3.1.1 Global Valsartan Sales by Manufacturer (2016-2021)
3.1.2 Global Valsartan Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Valsartan Manufacturers by Revenue
3.2.1 Key Valsartan Manufacturers Covered: Ranking by Revenue
3.2.2 Global Valsartan Revenue by Manufacturers (2016-2021)
3.2.3 Global Valsartan Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Valsartan Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Valsartan Revenue in 2020
3.2.6 Global Valsartan Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Valsartan Price by Manufacturers
3.4 Global Valsartan Manufacturing Base Distribution, Product Types
3.4.1 Valsartan Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Valsartan Product Type
3.4.3 Date of International Manufacturers Enter into Valsartan Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Valsartan Market Size by Type (2016-2021)
4.1.1 Global Valsartan Sales by Type (2016-2021)
4.1.2 Global Valsartan Revenue by Type (2016-2021)
4.1.3 Valsartan Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Valsartan Market Size Forecast by Type (2022-2027)
4.2.1 Global Valsartan Sales Forecast by Type (2022-2027)
4.2.2 Global Valsartan Revenue Forecast by Type (2022-2027)
4.2.3 Valsartan Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Valsartan Market Size by Application (2016-2021)
5.1.1 Global Valsartan Sales by Application (2016-2021)
5.1.2 Global Valsartan Revenue by Application (2016-2021)
5.1.3 Valsartan Price by Application (2016-2021)
5.2 Valsartan Market Size Forecast by Application (2022-2027)
5.2.1 Global Valsartan Sales Forecast by Application (2022-2027)
5.2.2 Global Valsartan Revenue Forecast by Application (2022-2027)
5.2.3 Global Valsartan Price Forecast by Application (2022-2027)
6 United States by Players, Type and Application
6.1 United States Valsartan Market Size YoY Growth 2016-2027
6.1.1 United States Valsartan Sales YoY Growth 2016-2027
6.1.2 United States Valsartan Revenue YoY Growth 2016-2027
6.1.3 United States Valsartan Market Share in Global Market 2016-2027
6.2 United States Valsartan Market Size by Players (International and Local Players)
6.2.1 United States Top Valsartan Players by Sales (2016-2021)
6.2.2 United States Top Valsartan Players by Revenue (2016-2021)
6.3 United States Valsartan Historic Market Review by Type (2016-2021)
6.3.1 United States Valsartan Sales Market Share by Type (2016-2021)
6.3.2 United States Valsartan Revenue Market Share by Type (2016-2021)
6.3.3 United States Valsartan Price by Type (2016-2021)
6.4 United States Valsartan Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Valsartan Sales Forecast by Type (2022-2027)
6.4.2 United States Valsartan Revenue Forecast by Type (2022-2027)
6.4.3 United States Valsartan Price Forecast by Type (2022-2027)
6.5 United States Valsartan Historic Market Review by Application (2016-2021)
6.5.1 United States Valsartan Sales Market Share by Application (2016-2021)
6.5.2 United States Valsartan Revenue Market Share by Application (2016-2021)
6.5.3 United States Valsartan Price by Application (2016-2021)
6.6 United States Valsartan Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Valsartan Sales Forecast by Application (2022-2027)
6.6.2 United States Valsartan Revenue Forecast by Application (2022-2027)
6.6.3 United States Valsartan Price Forecast by Application (2022-2027)
7 North America
7.1 North America Valsartan Market Size YoY Growth 2016-2027
7.2 North America Valsartan Market Facts & Figures by Country
7.2.1 North America Valsartan Sales by Country (2016-2021)
7.2.2 North America Valsartan Revenue by Country (2016-2021)
7.2.3 United States
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Valsartan Market Size YoY Growth 2016-2027
8.2 Asia Pacific Valsartan Market Facts & Figures by Region
8.2.1 Asia Pacific Valsartan Sales by Region (2016-2021)
8.2.2 Asia Pacific Valsartan Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Valsartan Market Size YoY Growth 2016-2027
9.2 Europe Valsartan Market Facts & Figures by Country
9.2.1 Europe Valsartan Sales by Country (2016-2021)
9.2.2 Europe Valsartan Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Valsartan Market Size YoY Growth 2016-2027
10.2 Latin America Valsartan Market Facts & Figures by Country
10.2.1 Latin America Valsartan Sales by Country (2016-2021)
10.2.2 Latin America Valsartan Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Valsartan Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Valsartan Market Facts & Figures by Country
11.2.1 Middle East and Africa Valsartan Sales by Country (2016-2021)
11.2.2 Middle East and Africa Valsartan Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Novartis
12.1.1 Novartis Corporation Information
12.1.2 Novartis Description and Business Overview
12.1.3 Novartis Valsartan Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Novartis Valsartan Products Offered
12.1.5 Novartis Recent Development
12.2 Sun Pharmaceutical
12.2.1 Sun Pharmaceutical Corporation Information
12.2.2 Sun Pharmaceutical Description and Business Overview
12.2.3 Sun Pharmaceutical Valsartan Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Sun Pharmaceutical Valsartan Products Offered
12.2.5 Sun Pharmaceutical Recent Development
12.3 Teva
12.3.1 Teva Corporation Information
12.3.2 Teva Description and Business Overview
12.3.3 Teva Valsartan Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Teva Valsartan Products Offered
12.3.5 Teva Recent Development
12.4 Mylan
12.4.1 Mylan Corporation Information
12.4.2 Mylan Description and Business Overview
12.4.3 Mylan Valsartan Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Mylan Valsartan Products Offered
12.4.5 Mylan Recent Development
12.5 Alembic Pharmaceuticals
12.5.1 Alembic Pharmaceuticals Corporation Information
12.5.2 Alembic Pharmaceuticals Description and Business Overview
12.5.3 Alembic Pharmaceuticals Valsartan Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Alembic Pharmaceuticals Valsartan Products Offered
12.5.5 Alembic Pharmaceuticals Recent Development
12.6 Lupin
12.6.1 Lupin Corporation Information
12.6.2 Lupin Description and Business Overview
12.6.3 Lupin Valsartan Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Lupin Valsartan Products Offered
12.6.5 Lupin Recent Development
12.7 Aurobindo Pharma
12.7.1 Aurobindo Pharma Corporation Information
12.7.2 Aurobindo Pharma Description and Business Overview
12.7.3 Aurobindo Pharma Valsartan Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Aurobindo Pharma Valsartan Products Offered
12.7.5 Aurobindo Pharma Recent Development
12.8 Macleods Pharmaceuticals
12.8.1 Macleods Pharmaceuticals Corporation Information
12.8.2 Macleods Pharmaceuticals Description and Business Overview
12.8.3 Macleods Pharmaceuticals Valsartan Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Macleods Pharmaceuticals Valsartan Products Offered
12.8.5 Macleods Pharmaceuticals Recent Development
12.9 HETERO
12.9.1 HETERO Corporation Information
12.9.2 HETERO Description and Business Overview
12.9.3 HETERO Valsartan Sales, Revenue and Gross Margin (2016-2021)
12.9.4 HETERO Valsartan Products Offered
12.9.5 HETERO Recent Development
12.10 Torrent Pharmaceuticals
12.10.1 Torrent Pharmaceuticals Corporation Information
12.10.2 Torrent Pharmaceuticals Description and Business Overview
12.10.3 Torrent Pharmaceuticals Valsartan Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Torrent Pharmaceuticals Valsartan Products Offered
12.10.5 Torrent Pharmaceuticals Recent Development
12.11 Novartis
12.11.1 Novartis Corporation Information
12.11.2 Novartis Description and Business Overview
12.11.3 Novartis Valsartan Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Novartis Valsartan Products Offered
12.11.5 Novartis Recent Development
12.12 Jubilant Pharma
12.12.1 Jubilant Pharma Corporation Information
12.12.2 Jubilant Pharma Description and Business Overview
12.12.3 Jubilant Pharma Valsartan Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Jubilant Pharma Products Offered
12.12.5 Jubilant Pharma Recent Development
12.13 Amneal Pharmaceuticals
12.13.1 Amneal Pharmaceuticals Corporation Information
12.13.2 Amneal Pharmaceuticals Description and Business Overview
12.13.3 Amneal Pharmaceuticals Valsartan Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Amneal Pharmaceuticals Products Offered
12.13.5 Amneal Pharmaceuticals Recent Development
12.14 Zhejiang Huahai Pharmaceutical
12.14.1 Zhejiang Huahai Pharmaceutical Corporation Information
12.14.2 Zhejiang Huahai Pharmaceutical Description and Business Overview
12.14.3 Zhejiang Huahai Pharmaceutical Valsartan Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Zhejiang Huahai Pharmaceutical Products Offered
12.14.5 Zhejiang Huahai Pharmaceutical Recent Development
12.15 Square Pharmaceuticals
12.15.1 Square Pharmaceuticals Corporation Information
12.15.2 Square Pharmaceuticals Description and Business Overview
12.15.3 Square Pharmaceuticals Valsartan Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Square Pharmaceuticals Products Offered
12.15.5 Square Pharmaceuticals Recent Development
12.16 Unichem Laboratories
12.16.1 Unichem Laboratories Corporation Information
12.16.2 Unichem Laboratories Description and Business Overview
12.16.3 Unichem Laboratories Valsartan Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Unichem Laboratories Products Offered
12.16.5 Unichem Laboratories Recent Development
12.17 LG Life Sciences
12.17.1 LG Life Sciences Corporation Information
12.17.2 LG Life Sciences Description and Business Overview
12.17.3 LG Life Sciences Valsartan Sales, Revenue and Gross Margin (2016-2021)
12.17.4 LG Life Sciences Products Offered
12.17.5 LG Life Sciences Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Valsartan Industry Trends
13.2 Valsartan Market Drivers
13.3 Valsartan Market Challenges
13.4 Valsartan Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Valsartan Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Valsartan Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of 40 mg Tablets
Table 3. Major Manufacturers of 80 mg Tablets
Table 4. Major Manufacturers of 160 mg Tablets
Table 5. Major Manufacturers of 320 mg Tablets
Table 6. Global Valsartan Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 7. Global Valsartan Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 8. Global Valsartan Sales by Regions (2016-2021) & (K Units)
Table 9. Global Valsartan Sales Market Share by Regions (2016-2021)
Table 10. Global Valsartan Revenue by Regions (2016-2021) & (US$ Million)
Table 11. Global Valsartan Sales Forecast by Region (2022-2027) & (K Units)
Table 12. Global Valsartan Sales Market Share Forecast by Region (2022-2027)
Table 13. Global Valsartan Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 14. Global Valsartan Revenue Market Share Forecast by Region (2022-2027)
Table 15. Global Valsartan Sales by Manufacturers (2016-2021) (K Units)
Table 16. Global Valsartan Sales Share by Manufacturers (2016-2021)
Table 17. Ranking of Global Top Valsartan Manufacturers by Revenue (US$ Million) in 2020
Table 18. Valsartan Revenue by Manufacturers (2016-2021) (US$ Million)
Table 19. Valsartan Revenue Share by Manufacturers (2016-2021)
Table 20. Global Valsartan Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 21. Global Valsartan by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Valsartan as of 2020)
Table 22. Key Manufacturers Valsartan Price (2016-2021) (US$/Unit)
Table 23. Valsartan Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Valsartan Product Type
Table 25. Date of International Manufacturers Enter into Valsartan Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Valsartan Sales by Type (2016-2021) (K Units)
Table 28. Global Valsartan Sales Share by Type (2016-2021)
Table 29. Global Valsartan Revenue by Type (2016-2021) (US$ Million)
Table 30. Global Valsartan Revenue Share by Type (2016-2021)
Table 31. Valsartan Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
Table 32. Global Valsartan Sales Forecast by Type (2022-2027) & (K Units)
Table 33. Global Valsartan Sales Market Share Forecast by Type (2022-2027)
Table 34. Global Valsartan Revenue Forecast V (2022-2027) & (US$ Million)
Table 35. Global Valsartan Revenue Market Share Forecast by Type (2022-2027)
Table 36. Global Valsartan Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
Table 37. Global Valsartan Sales by Application (2016-2021) (K Units)
Table 38. Global Valsartan Sales Share by Application (2016-2021)
Table 39. Global Valsartan Revenue by Application (2016-2021) (US$ Million)
Table 40. Global Valsartan Revenue Share by Application (2016-2021)
Table 41. Valsartan Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
Table 42. Global Valsartan Sales Forecast by Application (2022-2027) & (K Units)
Table 43. Global Valsartan Sales Market Share Forecast by Application (2022-2027)
Table 44. Global Valsartan Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 45. Global Valsartan Revenue Market Share Forecast by Application (2022-2027)
Table 46. Global Valsartan Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
Table 47. United States Valsartan Sales (K Units) of Key Companies (2016-2021)
Table 48. United States Valsartan Sales Share by Company (2016-2021)
Table 49. United States Valsartan Revenue (US$ Million) by Company (2016-2021)
Table 50. United States Valsartan Revenue Share by Company (2016-2021)
Table 51. United States Valsartan Sales (K Units) by Type (2016-2021)
Table 52. United States Valsartan Sales Share by Type (2016-2021)
Table 53. United States Valsartan Revenue (US$ Million) Market Share by Type (2016-2021)
Table 54. United States Valsartan Price (US$/Unit) by Type (2016-2021)
Table 55. United States Valsartan Sales (K Units) by Type (2022-2027)
Table 56. United States Valsartan Sales Share by Type (2022-2027)
Table 57. United States Valsartan Revenue (US$ Million) Market Share by Type (2022-2027)
Table 58. United States Valsartan Revenue Share by Type (2022-2027)
Table 59. United States Valsartan Price (US$/Unit) by Type (2022-2027)
Table 60. United States Valsartan Sales (K Units) by Application (2016-2021)
Table 61. United States Valsartan Sales Share by Application (2016-2021)
Table 62. United States Valsartan Revenue (US$ Million) Market Share by Application (2016-2021)
Table 63. United States Valsartan Price (US$/Unit) by Application (2016-2021)
Table 64. United States Valsartan Sales (K Units) by Application (2022-2027)
Table 65. United States Valsartan Sales Share by Application (2022-2027)
Table 66. United States Valsartan Revenue (US$ Million) Market Share by Application (2022-2027)
Table 67. United States Valsartan Revenue Share by Application (2022-2027)
Table 68. United States Valsartan Price (US$/Unit) by Application (2022-2027)
Table 69. North America Valsartan Sales by Country (2016-2021) & (K Units)
Table 70. North America Valsartan Sales Market Share by Country (2016-2021)
Table 71. North America Valsartan Revenue by Country (2016-2021) & (US$ Million)
Table 72. North America Valsartan Revenue Market Share by Country (2016-2021)
Table 73. Asia Pacific Valsartan Sales by Region (2016-2021) & (K Units)
Table 74. Asia Pacific Valsartan Sales Market Share by Region (2016-2021)
Table 75. Asia Pacific Valsartan Revenue by Region (2016-2021) & (US$ Million)
Table 76. Asia Pacific Valsartan Revenue Market Share by Region (2016-2021)
Table 77. Europe Valsartan Sales by Country (2016-2021) & (K Units)
Table 78. Europe Valsartan Sales Market Share by Country (2016-2021)
Table 79. Europe Valsartan Revenue by Country (2016-2021) & (US$ Million)
Table 80. Europe Valsartan Revenue Market Share by Country (2016-2021)
Table 81. Latin America Valsartan Sales by Country (2016-2021) & (K Units)
Table 82. Latin America Valsartan Sales Market Share by Country (2016-2021)
Table 83. Latin Americaa Valsartan Revenue by Country (2016-2021) & (US$ Million)
Table 84. Latin America Valsartan Revenue Market Share by Country (2016-2021)
Table 85. Middle East and Africa Valsartan Sales by Country (2016-2021) & (K Units)
Table 86. Middle East and Africa Valsartan Sales Market Share by Country (2016-2021)
Table 87. Middle East and Africa Valsartan Revenue by Country (2016-2021) & (US$ Million)
Table 88. Middle East and Africa Valsartan Revenue Market Share by Country (2016-2021)
Table 89. Novartis Corporation Information
Table 90. Novartis Description and Business Overview
Table 91. Novartis Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 92. Novartis Valsartan Product
Table 93. Novartis Recent Development
Table 94. Sun Pharmaceutical Corporation Information
Table 95. Sun Pharmaceutical Description and Business Overview
Table 96. Sun Pharmaceutical Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 97. Sun Pharmaceutical Product
Table 98. Sun Pharmaceutical Recent Development
Table 99. Teva Corporation Information
Table 100. Teva Description and Business Overview
Table 101. Teva Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 102. Teva Product
Table 103. Teva Recent Development
Table 104. Mylan Corporation Information
Table 105. Mylan Description and Business Overview
Table 106. Mylan Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 107. Mylan Product
Table 108. Mylan Recent Development
Table 109. Alembic Pharmaceuticals Corporation Information
Table 110. Alembic Pharmaceuticals Description and Business Overview
Table 111. Alembic Pharmaceuticals Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 112. Alembic Pharmaceuticals Product
Table 113. Alembic Pharmaceuticals Recent Development
Table 114. Lupin Corporation Information
Table 115. Lupin Description and Business Overview
Table 116. Lupin Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 117. Lupin Product
Table 118. Lupin Recent Development
Table 119. Aurobindo Pharma Corporation Information
Table 120. Aurobindo Pharma Description and Business Overview
Table 121. Aurobindo Pharma Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 122. Aurobindo Pharma Product
Table 123. Aurobindo Pharma Recent Development
Table 124. Macleods Pharmaceuticals Corporation Information
Table 125. Macleods Pharmaceuticals Description and Business Overview
Table 126. Macleods Pharmaceuticals Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 127. Macleods Pharmaceuticals Product
Table 128. Macleods Pharmaceuticals Recent Development
Table 129. HETERO Corporation Information
Table 130. HETERO Description and Business Overview
Table 131. HETERO Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 132. HETERO Product
Table 133. HETERO Recent Development
Table 134. Torrent Pharmaceuticals Corporation Information
Table 135. Torrent Pharmaceuticals Description and Business Overview
Table 136. Torrent Pharmaceuticals Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 137. Torrent Pharmaceuticals Product
Table 138. Torrent Pharmaceuticals Recent Development
Table 139. Huaren Pharmaceutical Corporation Information
Table 140. Huaren Pharmaceutical Description and Business Overview
Table 141. Huaren Pharmaceutical Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 142. Huaren Pharmaceutical Product
Table 143. Huaren Pharmaceutical Recent Development
Table 144. Jubilant Pharma Corporation Information
Table 145. Jubilant Pharma Description and Business Overview
Table 146. Jubilant Pharma Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 147. Jubilant Pharma Product
Table 148. Jubilant Pharma Recent Development
Table 149. Amneal Pharmaceuticals Corporation Information
Table 150. Amneal Pharmaceuticals Description and Business Overview
Table 151. Amneal Pharmaceuticals Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 152. Amneal Pharmaceuticals Product
Table 153. Amneal Pharmaceuticals Recent Development
Table 154. Zhejiang Huahai Pharmaceutical Corporation Information
Table 155. Zhejiang Huahai Pharmaceutical Description and Business Overview
Table 156. Zhejiang Huahai Pharmaceutical Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 157. Zhejiang Huahai Pharmaceutical Product
Table 158. Zhejiang Huahai Pharmaceutical Recent Development
Table 159. Square Pharmaceuticals Corporation Information
Table 160. Square Pharmaceuticals Description and Business Overview
Table 161. Square Pharmaceuticals Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 162. Square Pharmaceuticals Product
Table 163. Square Pharmaceuticals Recent Development
Table 164. Unichem Laboratories Corporation Information
Table 165. Unichem Laboratories Description and Business Overview
Table 166. Unichem Laboratories Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 167. Unichem Laboratories Product
Table 168. Unichem Laboratories Recent Development
Table 169. LG Life Sciences Corporation Information
Table 170. LG Life Sciences Description and Business Overview
Table 171. LG Life Sciences Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 172. LG Life Sciences Product
Table 173. LG Life Sciences Recent Development
Table 174. Valsartan Market Trends
Table 175. Valsartan Market Drivers
Table 176. Valsartan Market Challenges
Table 177. Valsartan Market Restraints
Table 178. Valsartan Customers List
Table 179. Valsartan Distributors List
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Valsartan Product Picture
Figure 2. Global Valsartan Sales Market Share by Type in 2020 & 2027
Figure 3. 40 mg Tablets Product Picture
Figure 4. 80 mg Tablets Product Picture
Figure 5. 160 mg Tablets Product Picture
Figure 6. 320 mg Tablets Product Picture
Figure 7. Global Valsartan Sales Market Share by Application in 2020 & 2027
Figure 8. Hypertension
Figure 9. Heart Failure
Figure 10. Heart Attack
Figure 11. Valsartan Report Years Considered
Figure 12. Global Valsartan Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Valsartan Market Size 2016-2027 (US$ Million)
Figure 14. Global Valsartan Sales 2016-2027 (K Units)
Figure 15. Global Valsartan Market Size Market Share by Region: 2021 Versus 2027
Figure 16. Global Valsartan Sales Market Share by Region (2016-2021)
Figure 17. Global Valsartan Sales Market Share by Region in 2020
Figure 18. Global Valsartan Revenue Market Share by Region (2016-2021)
Figure 19. Global Valsartan Revenue Market Share by Region in 2020
Figure 20. Global Valsartan Sales Share by Manufacturer in 2020
Figure 21. The Top 10 and 5 Players Market Share by Valsartan Revenue in 2020
Figure 22. Valsartan Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 23. Global Valsartan Sales Market Share by Type (2016-2021)
Figure 24. Global Valsartan Sales Market Share by Type in 2020
Figure 25. Global Valsartan Revenue Market Share by Type (2016-2021)
Figure 26. Global Valsartan Revenue Market Share by Type in 2020
Figure 27. Global Valsartan Sales Market Share by Application (2016-2021)
Figure 28. Global Valsartan Sales Market Share by Application in 2020
Figure 29. Global Valsartan Revenue Market Share by Application (2016-2021)
Figure 30. Global Valsartan Revenue Market Share by Application in 2020
Figure 31. United States Valsartan Sales Growth Rate 2016-2027 (K Units)
Figure 32. United States Valsartan Revenue Growth Rate 2016-2027 (US$ Million)
Figure 33. United States Valsartan Market Share in Global Market 2016-2027
Figure 34. United States 5 and 10 Largest Valsartan Players Market Share by Revenue in Valsartan in 2020
Figure 35. United States Valsartan Revenue Share by Type (2016-2021)
Figure 36. United States Valsartan Revenue Growth Rate by Type in 2016 & 2020
Figure 37. United States Valsartan Revenue Share by Application (2016-2021)
Figure 38. United States Valsartan Revenue Growth Rate by Application in 2016 & 2020
Figure 39. North America Valsartan Sales Growth Rate 2016-2021 (K Units)
Figure 40. North America Valsartan Revenue Growth Rate 2016-2021 (US$ Million)
Figure 41. North America Valsartan Sales Market Share by Country in 2020
Figure 42. North America Valsartan Revenue Market Share by Country in 2020
Figure 43. United States Valsartan Sales Growth Rate (2016-2021) (K Units)
Figure 44. United States Valsartan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Canada Valsartan Sales Growth Rate (2016-2021) (K Units)
Figure 46. Canada Valsartan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Europe Valsartan Sales Growth Rate 2016-2021 (K Units)
Figure 48. Europe Valsartan Revenue Growth Rate 2016-2021 (US$ Million)
Figure 49. Europe Valsartan Sales Market Share by Country in 2020
Figure 50. Europe Valsartan Revenue Market Share by Country in 2020
Figure 51. Germany Valsartan Sales Growth Rate (2016-2021) (K Units)
Figure 52. Germany Valsartan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. France Valsartan Sales Growth Rate (2016-2021) (K Units)
Figure 54. France Valsartan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. U.K. Valsartan Sales Growth Rate (2016-2021) (K Units)
Figure 56. U.K. Valsartan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Italy Valsartan Sales Growth Rate (2016-2021) (K Units)
Figure 58. Italy Valsartan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Russia Valsartan Sales Growth Rate (2016-2021) (K Units)
Figure 60. Russia Valsartan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Asia Pacific Valsartan Sales Growth Rate 2016-2021 (K Units)
Figure 62. Asia Pacific Valsartan Revenue Growth Rate 2016-2021 (US$ Million)
Figure 63. Asia Pacific Valsartan Sales Market Share by Region in 2020
Figure 64. Asia Pacific Valsartan Revenue Market Share by Region in 2020
Figure 65. China Valsartan Sales Growth Rate (2016-2021) (K Units)
Figure 66. China Valsartan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. Japan Valsartan Sales Growth Rate (2016-2021) (K Units)
Figure 68. Japan Valsartan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. South Korea Valsartan Sales Growth Rate (2016-2021) (K Units)
Figure 70. South Korea Valsartan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. India Valsartan Sales Growth Rate (2016-2021) (K Units)
Figure 72. India Valsartan Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Australia Valsartan Sales Growth Rate (2016-2021) (K Units)
Figure 74. Australia Valsartan Revenue
  • Global Pulmonary Arterial Hypertension (Pah) Medicine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Pulmonary Arterial Hypertension (Pah) Medicine market: According to our latest research, the global Pulmonary Arterial Hypertension (Pah) Medicine market looks promising in the next 5 years. As of 2022, the global Pulmonary Arterial Hypertension (Pah) Medicine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to ......
  • Global Nifedipine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 102
    Market Overview of Global Nifedipine market: According to our latest research, the global Nifedipine market looks promising in the next 5 years. As of 2022, the global Nifedipine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Nifedipine market, with a systematical de......
  • Global Amlodipine Besylate Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 115
    The Amlodipine Besylate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amlodipine Besylate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profil......
  • Pulmonary Arterial Hypertension (PAH) Drugs - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 112
    The global Pulmonary Arterial Hypertension (PAH) Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pulmonary Arterial Hypertension (PAH) Drugs in various end use industries. The expanding demands from the Hospitals, Clinics and Other,, are propelling Pulmonary Arterial Hypertension (PAH) Drugs market. Inhalation, one of the segments analysed in this report, is projected to record % ......
  • Captopril API - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 100
    The global Captopril API market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Captopril API in various end use industries. The expanding demands from the Captopril Tablet, Compound Captopril Tablet and Captopril Injection,, are propelling Captopril API market. 98% Captopril API, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the......
  • Telmisartan - Global Market Insights and Sales Trends 2024
    Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 107
    The global Telmisartan market size is expected to reach US$ 3631.3 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Telmisartan in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Telmisartan market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-Dried......
  • Global Ambrisentan Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 106
    Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......
  • Global Ambrisentan Market Research Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 2680 Onwards        Pages: 132
    Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......
  • Global Amlodipine Besylate Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 133
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs